Results 141 to 150 of about 9,057,173 (269)
Chromogenic Factor X Assay for Monitoring Warfarin Anticoagulation in a Child With a Prosthetic Mitral Valve. [PDF]
Greenmyer JR+4 more
europepmc +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
A Case Report of Acquired Factor X Deficiency in a Patient With Multiple Myeloma. [PDF]
Sabobeh T+4 more
europepmc +1 more source
Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation
Pericytes alter their transcriptome depending on their proximity to the tumor core. In the tumor core, pericytes display a more active state with higher communication strength but with lower immune activation potential and a shift toward extracellular matrix production.
Carolina Buizza+5 more
wiley +1 more source
Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity. [PDF]
Han G, Lee J, Bae JS.
europepmc +1 more source
Occurrence and management of severe bleeding episodes in patients with hereditary factor X deficiency. [PDF]
Tarantino MD.
europepmc +1 more source
STUDIES ON THE FACTORS AFFECTING THE REJOINING OF CHROMOSOME BREAKS PRODUCED BY X-RAYS
Shigeyuki Tanifuji+2 more
openalex +2 more sources
An Ansatz That F3(x, Q2) Displays Only the Form Factor Like Negative Scaling Violation [PDF]
K.-i. Matumoto, T. Tajima
openalex +1 more source